Endogenous Pigments

Slide 1 · Endogenous pigments

Cellular origin, morphology, and clinicopathologic interpretation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Distinguish pigments synthesized or generated within the body from exogenous pigment.

Explain lipofuscin formation, morphology, and its biological significance.

Describe melanin, ochronotic pigment, and hemoglobin-derived hemosiderin.

Integrate pigment location with local hemorrhage and systemic iron overload.

Slide 3 · Pigments in intracellular accumulations

Pigments are colored substances found in cells and tissues.

Some are normal constituents, whereas others accumulate in special circumstances.

The chemical origin of a pigment shapes its pathologic significance.

Endogenous pigment is made or generated within the body.

Chemical origin

Cellular localization

Clinical context

Slide 4 · Endogenous and exogenous sources

Endogenous

Exogenous

Generated within the body

Introduced from outside the body

Lipofuscin, melanin, hemosiderin

Carbon, tattoo pigment

Metabolism, synthesis, or degradation

Inhalation or direct deposition

Interpret together with cellular history

Interpret with exposure history

Slide 5 · Four entities in the core framework

Lipofuscin

Lipid-peroxidation residue

Melanin

Pigment synthesized in melanocytes

Homogentisic acid

Rare ochronotic pigment

Hemosiderin

Hemoglobin-derived iron store

Slide 6 · A useful pigment description is multidimensional

Describe color and granularity in routine tissue sections.

Identify the involved cell and subcellular location.

Ask whether the deposition is focal or distributed across organs.

Connect the finding to synthesis, turnover, hemorrhage, or overload.

Appearance + compartment

Local versus systemic

Biochemical origin

Slide 7 · Do not infer pathogenesis from color alone

Shared appearance

Different origin

Yellow–brown granules

Lipofuscin: Oxidized membrane lipids

Yellow–brown granules

Hemosiderin: Stored iron

Brown-black pigment

Melanin: Synthesis in melanocytes

Dark pigment in connective tissue

Ochronosis: Homogentisic acid

Slide 8 · The pigment pathway links substrate to deposit

Native substrate

Biochemical processing

Pigment retained

Morphologic finding

Interpretation follows the direction of the process

Slide 9 · Lipofuscin: Wear-and-tear pigment

Lipofuscin is an insoluble intracellular pigment.

It is also called lipochrome or wear-and-tear pigment.

Its characteristic yellow–brown granules are cytoplasmic.

Its major significance is evidence of previous oxidative membrane damage.

Schematic — lipofuscin granules (not a photomicrograph)

Slide 10 · The composition of lipofuscin is complex

The pigment contains polymers of lipids and phospholipids.

These components are complexed with proteins.

The composition implicates intracellular membrane lipids.

This is a pigment residue, not a functional storage form of iron.

Lipids

Phospholipids

Protein complexes

Slide 11 · Lipid peroxidation produces the precursor material

Membrane polyunsaturated lipids

Free-radical injury

Lipid peroxidation

Lipofuscin residue

Interpretation follows the direction of the process

Slide 12 · Why membrane composition matters

Polyunsaturated membrane lipids are substrates for peroxidative reactions.

Oxidative damage alters lipid components of intracellular membranes.

Lipofuscin composition reflects that damaged material.

Pigment is therefore a morphologic footprint of injury rather than its primary cause.

Membrane substrate

Peroxidative damage

Residual pigment

Slide 13 · Residual bodies connect autophagy and lipofuscin

Autophagic sequestration

Lysosomal digestion

Persistent residual material

Lipofuscin granules

Interpretation follows the direction of the process

Slide 14 · Lipofuscin localization is often perinuclear

In routine sections, granules are often near the nucleus.

Pigment lies in the cytoplasm, not within the nucleus.

The textbook figure caption notes intralysosomal localization.

Both color and location are useful descriptive clues.

Schematic — lipofuscin granules (not a photomicrograph)

Slide 15 · Histologic pattern in cardiac muscle

Fine, yellow–brown cytoplasmic granules are characteristic.

Granules are commonly concentrated near myocyte nuclei.

The pattern is particularly prominent in aging hearts.

Schematic — pigment distribution only; Not diagnostic microscopy

Slide 16 · The liver is another common site

Lipofuscin may be found in the cytoplasm of hepatocytes.

Increasing age is a common clinical context.

Severe malnutrition and cancer cachexia also favor conspicuous pigment.

Pigment alone does not establish a specific hepatic disease.

Schematic — pigment distribution only; Not diagnostic microscopy

Slide 17 · Lipofuscin and slow regressive change

Lipofuscin with slowly regressing cells.

The common examples are cardiac and hepatic cells.

Accumulation can accompany a chronic imbalance in turnover and clearance.

Interpret it against age, nutrition, and the broader tissue response.

Aging or chronic stress

Residual pigment persists

Contextual marker

Slide 18 · Cancer cachexia provides a clinical setting

Cancer cachexia is specifically identified as a context for prominent lipofuscin.

Cachexia can accompany tissue atrophy and catabolic change.

Lipofuscin marks chronic cellular stress rather than confirming a malignancy.

Clinical history is indispensable for interpretation.

Systemic catabolic state

Slow regressive changes

Visible lipofuscin

Slide 19 · Brown atrophy links pigment with tissue change

Autophagic residual bodies may persist in atrophic cells.

When sufficiently abundant, lipofuscin produces brown discoloration.

The source calls this appearance brown atrophy.

The pigmentation and the underlying atrophy are distinct observations.

Atrophy

Residual lipofuscin

Brown discoloration

Slide 20 · Lipofuscin is not itself injurious

Lipofuscin does not injure cells or their functions.

The biologically relevant antecedent is free-radical injury and lipid peroxidation.

Do not confuse a marker of damage with a damage-causing agent.

A small pigment burden cannot be used to stage tissue injury.

Prior oxidative stress

Inert pigment deposit

No direct cellular injury

Slide 21 · Lipofuscin case: An aging myocardium

An older patient has fine yellow–brown perinuclear granules in cardiac myocytes without a stated iron-overload history.

What is the most source-supported interpretation?

Lipofuscin is favored by the color, fine granularity, perinuclear localization, and aging context. The finding is a marker of prior lipid peroxidation—not proof of pigment-induced myocyte injury.

Slide 22 · Lipofuscin: Which observations matter?

Helpful observation

Interpretive consequence

Fine perinuclear granules

Supports lipofuscin morphology

Liver or cardiac muscle

Recognized common sites

Aging, malnutrition, cachexia

Plausible associated contexts

No stated cellular dysfunction

Compatible with a noninjurious pigment

Slide 23 · Melanin is synthesized within the body

Melanin is a brown–black endogenous pigment.

Its producing cells are melanocytes.

The relevant biochemical conversion requires tyrosinase.

Unlike lipofuscin, melanin is the product of a specific pigment-synthesis pathway.

Schematic — melanin granules (not a photomicrograph)

Slide 24 · Tyrosinase initiates the described conversion

Tyrosine

Tyrosinase-catalyzed oxidation

Dihydroxyphenylalanine (DOPA)

Melanin formation

Interpretation follows the direction of the process

Slide 25 · Tyrosine is the pigment precursor

The source begins the pathway with tyrosine.

Tyrosinase catalyzes tyrosine oxidation to DOPA.

This explains why melanin belongs among synthesized endogenous pigments.

The text does not present a complete downstream reaction sequence.

Substrate: Tyrosine

Enzyme: Tyrosinase

Product pathway: Melanin

Slide 26 · Melanin differs from passive cellular residue

Melanin

Lipofuscin

Synthesized by melanocytes

Derived from membrane lipid peroxidation

Tyrosinase is involved

Reflects oxidative lipid damage

Brown–black

Yellow–brown

Physiologic pigment

Wear-and-tear residue

Slide 27 · Pigment color alone is insufficient

Melanin is described as brown–black.

Hemosiderin can appear yellow–brown to brown.

Lipofuscin also appears yellow–brown and finely granular.

Cell type, pigment distribution, and clinical context refine recognition.

Observe the color

Locate the pigment

Determine the origin

Slide 28 · Homogentisic acid is the rare exception

The text identifies homogentisic acid as another endogenous black pigment.

It is found in patients with alkaptonuria.

Alkaptonuria is described as a rare metabolic disease.

Pigment deposition here is not melanocytic synthesis.

Alkaptonuria

Homogentisic acid

Ochronotic deposition

Slide 29 · Ochronosis denotes tissue pigmentation

Homogentisic acid-derived pigment accumulates in tissues.

Skin, connective tissue, and cartilage.

The resulting discoloration is known as ochronosis.

Its location and metabolic background distinguish it from melanin.

Skin

Connective tissue

Cartilage

Slide 30 · Ochronotic pigment: Recognize the site

Tissue compartment

Core implication

Skin

Visible endogenous pigmentation

Connective tissue

Nonmelanocytic pigment deposition

Cartilage

Characteristic connective-tissue site

Systemic metabolic context

Alkaptonuria

Slide 31 · Melanin versus ochronosis

Property

Melanin

Ochronosis

Chemical origin

Tyrosine pathway

Homogentisic acid

Cell/tissue context

Melanocytes

Skin, connective tissue, cartilage

Associated condition

Normal pigment synthesis

Alkaptonuria

Morphologic color

Brown–black

Black

Slide 32 · Clinical problem: Dark cartilage

A patient with a rare inherited metabolic disorder develops dark pigment deposition in cartilage and connective tissue.

Which pigment pathway best explains the tissue change?

Homogentisic acid accumulation in alkaptonuria produces ochronosis. The tissue distribution and metabolic context distinguish this process from tyrosinase-dependent melanin synthesis.

Slide 33 · Hemosiderin stores iron within cells

Hemosiderin is a major storage form of iron.

It is derived from hemoglobin.

Its appearance ranges from golden-yellow to brown.

It may form granular or crystalline deposits visible by light microscopy.

Schematic — hemosiderin granules (not a photomicrograph)

Slide 34 · Hemosiderin is not the transport form

Transport

Intracellular storage

Transferrin carries iron in plasma

Ferritin binds iron inside many cells

Delivers iron to cells

Apoferritin is the protein component

Dynamic iron movement

Hemosiderin appears as aggregated storage material

Slide 35 · From apoferritin to ferritin

Intracellular iron

Association with apoferritin

Ferritin complexes

Micellar iron storage

Interpretation follows the direction of the process

Slide 36 · Ferritin can aggregate into hemosiderin

Ferritin micelles

Local or systemic iron excess

Ferritin aggregates

Hemosiderin granules

Interpretation follows the direction of the process

Slide 37 · The lysosome contributes to iron storage

Chapter 14 describes hemosiderin granules after ferritin aggregation.

Partial lysosomal degradation contributes to this process.

Hemosiderin becomes especially conspicuous in iron-overloaded cells.

The stored iron remains chemically demonstrable.

Ferritin aggregates

Lysosomal processing

Hemosiderin

Slide 38 · Normal hemosiderin is not always abnormal

Small amounts normally occur in mononuclear phagocytes.

Common sites are bone marrow, spleen, and liver.

These cells process senescent circulating erythrocytes.

Interpret the quantity and distribution before declaring iron overload.

Bone marrow

Spleen

Liver

Slide 39 · Macrophages recycle erythrocyte iron

Senescent red cells

Mononuclear phagocytes

Hemoglobin breakdown

Iron recovery

Interpretation follows the direction of the process

Slide 40 · Iron recycling links blood and tissue

Phagocytes recover iron from aging red cells.

Recovered iron can reenter circulating transferrin.

Iron can be retained intracellularly as ferritin or hemosiderin.

Normal storage does not imply pathologic tissue hemorrhage.

Red cell turnover

Macrophage processing

Reuse or storage

Slide 41 · Localized iron accumulation follows hemorrhage

Tissue hemorrhage

Extravascular red cells

Macrophage erythrophagocytosis

Hemosiderin deposition

Interpretation follows the direction of the process

Slide 42 · The bruise is localized hemosiderosis

A bruise is a familiar example of local excess iron.

Red cells leave the vasculature after tissue injury.

Macrophages ingest these cells over subsequent days.

Pigment evolves as hemoglobin components are processed.

Schematic — pigment distribution only; Not diagnostic microscopy

Slide 43 · Hemoglobin breakdown has parallel products

Hemoglobin from ingested red cells

Heme pigment pathway:

Biliverdin → bilirubin

Recovered iron:

Ferritin → hemosiderin

Slide 44 · The heme pigment branch changes color

Heme after iron removal

Biliverdin

Bilirubin

Resolving discoloration

Interpretation follows the direction of the process

Slide 45 · The iron branch produces the storage pigment

Iron released from heme

Intracellular ferritin

Hemosiderin granules

Residual brown pigment

Interpretation follows the direction of the process

Slide 46 · Why a bruise changes appearance

Color reflects overlapping stages of blood breakdown.

Biliverdin contributes a green phase in the heme pathway.

Bilirubin contributes a yellow phase.

Iron is retained in ferritin and hemosiderin along a parallel branch.

Red–blue

Green–blue

Golden–yellow

Color progression is illustrative; Timing varies

Slide 47 · Bruise coloration is a sequence, not a clock

Red–blue, green–blue, and golden–yellow phases.

Different stages overlap as tissue products are cleared.

The color pattern illustrates hemoglobin catabolism.

The excerpt does not provide a validated method for dating a bruise.

Red–blue

Green–blue

Golden–yellow

Color progression is illustrative; Timing varies

Slide 48 · Hemosiderin morphology in phagocytes

Deposits appear golden-yellow to brown on routine examination.

Material may be granular or crystalline.

Macrophage cytoplasm is a plausible site after hemorrhage.

The schematic depicts pigment location without reproducing a real section.

Schematic — pigment distribution only; Not diagnostic microscopy

Slide 49 · Perls Prussian blue identifies stored iron

Chapter 14 describes a reaction with potassium ferrocyanide.

Iron in hemosiderin turns blue–black in the Prussian blue reaction.

This supports identification of iron-containing pigment in tissue.

The method detects iron; It is not by itself a diagnosis of systemic overload.

Iron-containing granules

Potassium ferrocyanide

Blue–black reaction

Slide 50 · Local versus systemic hemosiderosis

Localized

Systemic

Previous tissue hemorrhage

Body-wide iron excess

Bruise as example

Multiple organs can be involved

Macrophage processing of blood

Increased input or iron absorption

Does not alone show systemic loading

Search for the systemic cause

Slide 51 · Systemic hemosiderosis reflects excess iron

Systemic overload allows hemosiderin to accumulate in many organs.

This pattern differs from iron confined to one prior hemorrhage.

Three major categories of cause.

Cause and organ distribution guide interpretation.

Increased absorption

Excess red-cell destruction

Repeated transfusions

Slide 52 · Increased absorption: Hemochromatosis

An inherited error can increase intestinal iron absorption.

This produces progressive accumulation of total body iron.

Hemosiderin deposits in tissues when storage capacity is exceeded.

Further disease-specific discussion appears Chapter 18.

Inborn metabolic error

Increased dietary iron uptake

Tissue iron deposits

Slide 53 · Excessive hemolysis increases the iron load

Hemolytic anemias cause increased destruction of red cells.

Breakdown of excessive erythrocyte mass liberates more hemoglobin-derived iron.

Additional iron can be held in the macrophage storage system.

Such conditions are listed among major causes of systemic hemosiderosis.

Excess RBC destruction

Iron recovery burden

Tissue storage

Slide 54 · Repeated transfusion is another iron source

Transfused red cells carry an additional iron load into the body.

Repeated transfusions can progressively increase body iron.

This exposure among the major causes of hemosiderosis.

The source does not supply a diagnostic transfusion-count threshold.

Repeated red-cell transfusion

Accumulated iron input

Systemic iron storage

Slide 55 · When iron overload becomes tissue injury

Hemosiderosis describes excess iron deposition.

Severe hemochromatosis may also damage parenchymal tissues.

Chapter 18 describes liver injury, cirrhosis, and pancreatic fibrosis.

The severity of organ injury is not defined by pigment color alone.

Liver

Pancreas

Heart

Slide 56 · Iron-loading diseases require contextual diagnosis

Finding

Clinical interpretation

Small phagocyte deposits

Can occur during normal erythrocyte turnover

Focal pigment after bleed

Localized hemosiderosis

Multiorgan iron deposition

Consider systemic overload

Parenchymal damage with overload

Consider hemochromatosis-related injury

Slide 57 · Case: Pigment at an old hemorrhage

An organizing soft-tissue hemorrhage contains macrophages with coarse yellow–brown cytoplasmic granules.

Which mechanism is the most direct explanation?

Extravasated erythrocytes were phagocytosed. Their hemoglobin was degraded, and recovered iron was stored first in ferritin and then in hemosiderin. This is localized hemosiderosis.

Slide 58 · Case: Multiorgan iron deposition

A patient receiving long-term repeated red-cell transfusions has iron-containing pigment in multiple tissues.

Which upstream exposure explains the deposition?

Repeated transfusions supply iron through the transfused erythrocytes. Their cumulative breakdown can produce systemic hemosiderosis; Organ injury must be assessed separately.

Slide 59 · Integrated pigment comparison

Pigment

Origin

Usual clue

Lipofuscin

Oxidized membrane lipid residue

Fine perinuclear yellow–brown

Melanin

Tyrosinase-dependent synthesis

Brown–black in melanocytic setting

Ochronotic pigment

Homogentisic acid in alkaptonuria

Pigmented cartilage/connective tissue

Hemosiderin

Iron derived from hemoglobin

Coarse yellow–brown; Iron reaction

Slide 60 · A practical tissue-pigment workflow

Find colored deposit

Define cell and location

Choose biochemical mechanism

Integrate clinical pattern

Interpretation follows the direction of the process

Slide 61 · Integrated interpretation: Three mistakes

Do not label every brown granule as iron.

Do not equate lipofuscin with direct pigment toxicity.

Do not assume a local bruise indicates systemic iron overload.

Do not classify ochronosis as melanin without considering alkaptonuria.

Describe, then classify

Mechanism matters

Distribution matters

Slide 62 · Knowledge check: Identify the mechanism

A pathologist encounters: (A) cardiac perinuclear fine granules, (B) pigmented cartilage in alkaptonuria, and (C) iron-rich phagocytes following hemorrhage.

Match each morphology to the causal process.

A — Lipid peroxidation and residual lipofuscin. B — Homogentisic acid deposition (ochronosis). C — Hemoglobin breakdown and storage of recovered iron as hemosiderin.

Slide 63 · Core synthesis

Lipofuscin

Inert trace of prior lipid peroxidation

Melanin

Tyrosinase-related pigment synthesis

Ochronosis

Alkaptonuria-associated homogentisic acid

Hemosiderin

Normal recycling or pathologic iron loading

Slide 64 · Reading and verification

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Intracellular Accumulations — Pigments.

Mechanisms of Atrophy: autophagic residual bodies and brown atrophy.

Iron Metabolism: ferritin, hemosiderin, and Prussian blue reaction.

Hemochromatosis: systemic iron loading and organ injury.